|
Latest Paper:
Bioorg Med Chem. 2012 Apr 28;:
22583669
State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, PR China.
A series of novel 4,5-dihydropyrazole derivatives containing niacinamide moiety as potential V600E mutant BRAF kinase (BRAF(V600E)) inhibitors were designed and synthesized. Results of the bioassays against BRAF(V600E) and WM266.4 human melanoma cell line showed several compounds to be endowed potent activities with IC(50) and GI(50) value in low micromolar range, among which compound 27e,(5-(4-Chlorophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)6-methylpyridin-3-yl methanone (IC(50)=0.20μM, GI(50)=0.89μM) was bearing the best bioactivity comparable with the positive control Sorafenib. Docking simulation was performed to determine the probable binding model and 3D-QSAR model was built to provide more pharmacophore understanding that could use to design new agents with more potent BRAF(V600E) inhibitory activity.
Oxyfluoride glasses containing Ag species and rare earth (RE) ions (Dy<sup>3+</sup>, Sm<sup>3+</sup>, Tb<sup>3+</sup>) were prepared by melt-quenching technique. The type of luminescent species of novel excitation band (230-300 nm peaked at 255 nm) and emission band (300-600 nm peaked at 350 nm) were investigated by absorption, excitation, emission spectra, as well as decay lifetime measurements and can be ascribed to isolated Ag<sup>+</sup> ions. Owing to energy transfer from Ag<sup>+</sup> to RE ions, significant enhancements of RE ions emission (76 times for Sm<sup>3+</sup>, 41 times for Dy<sup>3+</sup>) were observed for non-resonant UV excitation (255 nm). Our research may extend the understanding of interactions between RE ions and Ag species.
Department of Medical Biology, Hubei University of Medicine, Hubei, PRC.
Using the protein-protein docking program, this study investigates the relationship between TRAF2 and its related proteins and the diversity within the 3D structures of TRAF2s. TRAF2 exists in monomer, trimer, and hexamer forms and it can combine with a number of proteins. Through comparative analysis we found that TRAF2(122), TRAF2(22), TRAF2(21740), TRAF2(2), TRAF2( 22ABC), and TRAF2(Phyre) perform very close homoousia in docking with the same group of ligands, though these TRAF2s come from different sources. The TRAF2-related proteins of cluster 1 change docking values strongly from top to bottom. The TRAF2- related proteins of clusters 2 and 3 have acceptable variation of the docking values. In consideration of the amino acid percentage, TRAF2-related proteins of cluster 2 represent appropriate docking values.
Department of Pharmacology, Harbin Medical University (the State-Province Key Laboratory of Biomedicine-Pharmaceutics of China), Harbin, China.
Neuropeptide Y (NPY) is an important neuronal element involved in cardiovascular regulation. Since elevated plasma levels of NPY have been observed in numerous pathological situations, this study aimed to determine whether long-term elevated plasma concentrations of NPY could result in aberrant baroreflex sensitivity. Mini-osmotic pump containing NPY (85 μg per 30 days) was subcutaneously implanted between scapulae in male rats for 4 months. The rats treated with NPY showed the following characters compared with control group:(1) attenuated heart rate responding to the increases in mean arterial blood pressure (MABP) induced by phenylephrine, but enhanced heart rate responding to the decreases in MABP induced by sodium nitroprusside;(2) decreased protein levels of substance P (SP) and GluR2, while increased the expression of γ-aminobutyric acid A receptor (GABA(A)R) in brainstem;(3) abdominal obesity indicated by increased body weight and accumulated fat mass in peritoneal cavity;(4) significant increases in total cholesterol, triglycerides, and low density lipoprotein levels in the periphery. These findings indicate that long-term NPY administration in the periphery leads to abnormal baroreflex sensitivity due, at least in part, to the down-regulated expression of SP/GluR2 and elevated expression of GABA(A)R in both protein and RNA levels, which indicate the alternations in glutamate function and GABA action in the nucleus tractus solitarii in NPY-treated rats. Furthermore, long-term NPY administration results in abdominal obesity and dyslipidemia.
A Adare,
S Afanasiev,
C Aidala,
N N Ajitanand,
Y Akiba,
H Al-Bataineh,
J Alexander,
K Aoki,
Y Aramaki,
E T Atomssa,
R Averbeck,
T C Awes,
B Azmoun,
V Babintsev,
M Bai,
G Baksay,
L Baksay,
K N Barish,
B Bassalleck,
A T Basye,
S Bathe,
V Baublis,
C Baumann,
A Bazilevsky,
S Belikov,
R Belmont,
R Bennett,
A Berdnikov,
Y Berdnikov,
A A Bickley,
J S Bok,
K Boyle,
M L Brooks,
H Buesching,
V Bumazhnov,
G Bunce,
S Butsyk,
C M Camacho,
S Campbell,
C-H Chen,
C Y Chi,
M Chiu,
I J Choi,
R K Choudhury,
P Christiansen,
T Chujo,
P Chung,
O Chvala,
V Cianciolo,
Z Citron,
B A Cole,
M Connors,
P Constantin,
M Csanád,
T Csörgő,
T Dahms,
S Dairaku,
I Danchev,
K Das,
A Datta,
G David,
A Denisov,
A Deshpande,
E J Desmond,
O Dietzsch,
A Dion,
M Donadelli,
O Drapier,
A Drees,
K A Drees,
J M Durham,
A Durum,
D Dutta,
S Edwards,
Y V Efremenko,
F Ellinghaus,
T Engelmore,
A Enokizono,
H En'yo,
S Esumi,
B Fadem,
D E Fields,
M Finger,
M Finger Jr,
F Fleuret,
S L Fokin,
Z Fraenkel,
J E Frantz,
A Franz,
A D Frawley,
K Fujiwara,
Y Fukao,
T Fusayasu,
I Garishvili,
A Glenn,
H Gong,
M Gonin,
Y Goto,
R Granier de Cassagnac,
N Grau,
S V Greene,
M Grosse Perdekamp,
T Gunji,
H-Å Gustafsson,
J S Haggerty,
K I Hahn,
H Hamagaki,
J Hamblen,
R Han,
J Hanks,
E P Hartouni,
E Haslum,
R Hayano,
X He,
M Heffner,
T K Hemmick,
T Hester,
J C Hill,
M Hohlmann,
W Holzmann,
K Homma,
B Hong,
T Horaguchi,
D Hornback,
S Huang,
T Ichihara,
R Ichimiya,
J Ide,
Y Ikeda,
K Imai,
M Inaba,
D Isenhower,
M Ishihara,
T Isobe,
M Issah,
A Isupov,
D Ivanischev,
B V Jacak,
J Jia,
J Jin,
B M Johnson,
K S Joo,
D Jouan,
D S Jumper,
F Kajihara,
S Kametani,
N Kamihara,
J Kamin,
J H Kang,
J Kapustinsky,
K Karatsu,
D Kawall,
M Kawashima,
A V Kazantsev,
T Kempel,
A Khanzadeev,
K M Kijima,
B I Kim,
D H Kim,
D J Kim,
E Kim,
E J Kim,
S H Kim,
Y J Kim,
E Kinney,
K Kiriluk,
A Kiss,
E Kistenev,
L Kochenda,
B Komkov,
M Konno,
J Koster,
D Kotchetkov,
A Kozlov,
A Král,
A Kravitz,
G J Kunde,
K Kurita,
M Kurosawa,
Y Kwon,
G S Kyle,
R Lacey,
Y S Lai,
J G Lajoie,
A Lebedev,
D M Lee,
J Lee,
K Lee,
K B Lee,
K S Lee,
M J Leitch,
M A L Leite,
E Leitner,
B Lenzi,
X Li,
P Liebing,
L A Linden Levy,
T Liška,
A Litvinenko,
H Liu,
M X Liu,
B Love,
R Luechtenborg,
D Lynch,
C F Maguire,
Y I Makdisi,
A Malakhov,
M D Malik,
V I Manko,
E Mannel,
Y Mao,
H Masui,
F Matathias,
M McCumber,
P L McGaughey,
N Means,
B Meredith,
Y Miake,
A C Mignerey,
P Mikeš,
K Miki,
A Milov,
M Mishra,
J T Mitchell,
A K Mohanty,
Y Morino,
A Morreale,
D P Morrison,
T V Moukhanova,
J Murata,
S Nagamiya,
J L Nagle,
M Naglis,
M I Nagy,
I Nakagawa,
Y Nakamiya,
T Nakamura,
K Nakano,
J Newby,
M Nguyen,
R Nouicer,
A S Nyanin,
E O'Brien,
S X Oda,
C A Ogilvie,
M Oka,
K Okada,
Y Onuki,
A Oskarsson,
M Ouchida,
K Ozawa,
R Pak,
V Pantuev,
V Papavassiliou,
I H Park,
J Park,
S K Park,
W J Park,
S F Pate,
H Pei,
J-C Peng,
H Pereira,
V Peresedov,
D Yu Peressounko,
C Pinkenburg,
R P Pisani,
M Proissl,
M L Purschke,
A K Purwar,
H Qu,
J Rak,
A Rakotozafindrabe,
I Ravinovich,
K F Read,
K Reygers,
V Riabov,
Y Riabov,
E Richardson,
D Roach,
G Roche,
S D Rolnick,
M Rosati,
C A Rosen,
S S E Rosendahl,
P Rosnet,
P Rukoyatkin,
P Ružička,
B Sahlmueller,
N Saito,
T Sakaguchi,
K Sakashita,
V Samsonov,
S Sano,
T Sato,
S Sawada,
K Sedgwick,
J Seele,
R Seidl,
A Yu Semenov,
R Seto,
D Sharma,
I Shein,
T-A Shibata,
K Shigaki,
M Shimomura,
K Shoji,
P Shukla,
A Sickles,
C L Silva,
D Silvermyr,
C Silvestre,
K S Sim,
B K Singh,
C P Singh,
V Singh,
M Slunečka,
R A Soltz,
W E Sondheim,
S P Sorensen,
I V Sourikova,
N A Sparks,
P W Stankus,
E Stenlund,
S P Stoll,
T Sugitate,
A Sukhanov,
J Sziklai,
E M Takagui,
A Taketani,
R Tanabe,
Y Tanaka,
K Tanida,
M J Tannenbaum,
S Tarafdar,
A Taranenko,
P Tarján,
H Themann,
T L Thomas,
M Togawa,
A Toia,
L Tomášek,
H Torii,
R S Towell,
I Tserruya,
Y Tsuchimoto,
C Vale,
H Valle,
H W van Hecke,
E Vazquez-Zambrano,
A Veicht,
J Velkovska,
R Vértesi,
A A Vinogradov,
M Virius,
V Vrba,
E Vznuzdaev,
X R Wang,
D Watanabe,
K Watanabe,
Y Watanabe,
F Wei,
R Wei,
J Wessels,
S N White,
D Winter,
J P Wood,
C L Woody,
R M Wright,
M Wysocki,
W Xie,
Y L Yamaguchi,
K Yamaura,
R Yang,
A Yanovich,
J Ying,
S Yokkaichi,
Z You,
G R Young,
I Younus,
I E Yushmanov,
W A Zajc,
C Zhang,
S Zhou,
L Zolin
University of Colorado, Boulder, Colorado 80309, USA.
Flow coefficients v_{n} for n=2, 3, 4, characterizing the anisotropic collective flow in Au+Au collisions at sqrt[s_{NN}]=200 GeV, are measured relative to event planes Ψ_{n}, determined at large rapidity. We report v_{n} as a function of transverse momentum and collision centrality, and study the correlations among the event planes of different order n. The v_{n} are well described by hydrodynamic models which employ a Glauber Monte Carlo initial state geometry with fluctuations, providing additional constraining power on the interplay between initial conditions and the effects of viscosity as the system evolves. This new constraint can serve to improve the precision of the extracted shear viscosity to entropy density ratio η/s.
Rochelle Wei,
Arunabh Bhattacharya,
Naveen Chintalaramulu,
Amanda L Jernigan,
Yuhong Liu,
Holly Van Remmen,
Asish R Chaudhuri
Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, TX 78229-3900, USA.
Mutant superoxide dismutase 1 (mSOD1) is often found as aggregates at the outer-membrane of mitochondria in motor neurons of various mouse models and familial amyotrophic lateral sclerosis (f-ALS) patients. It has been postulated that disruption of mitochondrial function by physical association of misfolded mSOD1 aggregates may actually be the trigger for initiation of degeneration of motor neurons in ALS. However, it was not clear if the same mechanism is involved in muscle degeneration and mitochondrial dysfunction in skeletal muscles of ALS. Recent study from our laboratory show that two skeletal muscle proteins, namely creatine kinase (CK) and glyceraldehydes-3-phosphate dehydrogenase (GAPDH) undergo major conformational and functional changes in the f-ALS mouse model of ALS (G93A). In this paper, we report two intriguing observations which are as follows:(i) G93A protein does not form aggregates in skeletal muscle at any stages of disease process probably due to high chymotrypsin-like activity of proteasome and thus G93A protein aggregates have no direct effects on progressive loss of muscle mass and global changes in protein conformation in ALS, and (ii) the soluble G93A protein does not have direct effects on mitochondrial dysfunction as determined by quantifying the release of reactive oxygen species (ROS) in skeletal muscle mitochondria; instead, the proteins affected by G93A possibly affect mitochondrial ROS release. These data strongly suggest for the first time that unlike in motor neurons, the soluble and aggregation states of the G93A protein do not have direct effects on protein misfolding and mitochondrial dysfunction in skeletal muscle during ALS.
Chem Commun (Camb). 2011 Dec 8;:
22158705
Department of Chemical Engineering, Laboratory for Advanced Materials, Tsinghua University, Beijing 100084, P. R. China. heyaning@mail.tsinghua.edu.cn wxg-dce@mail.tisnghua.edu.cn.
This communication reports a new approach to synthesize amphiphilic block copolymers. The copolymers with well-defined structures were synthesized by macromolecular azo-coupling reaction between the diazonium salt of aniline-functionalized PEG and the polymeric blocks with a terminal suitable for the azo-coupling reaction.
Am J Med Sci. 2011 Nov 16;:
22157385
From the Department of Nephrology of General Hospital of PLA (rw, rd, lt); and Institute of Aviation Medicine of Air Force (yw), PLA, Beijing, China.
Activation of reactive oxygen species and inflammation are implicated in renal ischemia/reperfusion (I/R) injuries. This study investigated whether grape seed proanthocyanidin extract (GSPE) protects against renal I/R injury by its effect on reactive oxygen species and the inflammation pathway. Wistar rats were administered GSPE before renal ischemia, followed by reperfusion for 24 hours. Plasma concentrations of urea, creatinine and cystatin C were measured for renal dysfunction. Serum and tissue superoxide dismutase activity and glutathione peroxidase and malondialdehyde levels were measured. Renal sections were analyzed for histological grading of renal injury, and nuclear factor-κB activity was determined. GSPE significantly reduced increases in urea, creatinine and cystatin C; increased kidney superoxide dismutase activity and glutathione peroxidase levels and reduced malondialdehyde levels. GSPE reduced histological renal damage and nuclear factor-κB activity. These results suggest that GSPE reduces renal dysfunction and injury caused by renal I/R.
Pharm Res. 2011 Dec 2;:
22134780
Otto H. York Dept. of Chemical, Biological & Pharmaceutical Engineering, New Jersey Institute of Technology, Newark, New Jersey, 07102, USA.
PURPOSE: To analyze the effects of chemical enhancers and iontophoresis on the buccal transmucosal delivery of lidocaine and nicotine. METHODS: Porcine oral mucosal samples were pretreated with chemical enhancers before conducting 8-hr Franz diffusion-cell experiments. In studies addressing the influence of iontophoresis on molecular transport, the current density was set at 0.3 mA/cm(2). Data were analyzed using graphical and non-linear regression optimization techniques. RESULTS: Both permeation enhancement techniques promote drug transport. In the absence of electricity, the flux increased as high as 4- and 200-fold, relative to a control, in the case of lidocaine hydrochloride (LHCl) and nicotine hydrogen tartrate (NHT) gel formulations, respectively. The combination of iontophoresis and chemical enhancers produced an even higher flux compared to the original passive diffusion process: up to 8-fold for LHCl and 450-fold for NHT. Mostly, the current helped to decrease the response time. However, a balance should be maintained between reaching a high delivery rate and reducing the time it takes to attain a desired flux value. In addition, the influence of chemical enhancers was drug-specific. CONCLUSIONS: The estimation of model parameters allows for a systematic approach to the design of chemical and physical penetration enhancers for transmucosal drug delivery.
School of Geographical Sciences and Urban Planning, Arizona State University, P.O. Box 875302, Tempe, Arizona, USA. paul.maliszewski@asu.edu
The 2009 H1N1 influenza A virus subtype (H1N1) pandemic had a large impact in the United States of America (USA), causing an estimated 192,000 to 398,000 hospitalizations and 8,720 to 18,050 deaths between April 2009 and mid-March 2010. Recent research on the 2009 H1N1 pandemic has largely focused on individual, non-spatial demographic characterizations (e.g. age and race/ethnicity) associated with H1N1 hospitalizations. Broader ecological factors such as transportation use, land use and other socioeconomic factors are important aspects of influenza studies that have not been empirically examined. This research explores and identifies ecological factors associated with 2009 H1N1 pandemic hospitalization rates. We conducted a spatial regression analysis of county level hospitalization rates from 3 April to 15 September, 2009 obtained via the California Department of Public Health. Hospitalization rates were found to be spatially dependent. Public transportation usage rates and agricultural land use proportions were significant environmental factors positively related to hospitalization rates. Consistent with public health official's assumptions and existing evidence, county percentages of persons less than 18 years of age were positively associated with hospitalization. These findings help to clarify the limited consensus and dubious evidence on the role of broader ecological factors associated with pandemic influenza. A better understanding of the ecological risk factors associated with hospitalizations should also benefit public health officials with respect to their work aiming at improving emergency supply allocation and non-pharmaceutical intervention strategies in the context of an influenza pandemic.
|
Polish News | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|